(Reuters) - LONDON, June 20 - British medical experts have
recommended that girls aged 12 to 13 should be routinely
vaccinated against a virus that causes most cases of cervical
cancer, the Department of Health said on Wednesday.
The move follows similar recommendations in other countries
and is a further boost for Merck & Co Inc. and
Sanofi-Aventis SA , who jointly market Gardasil, the
only such vaccine so far approved in Europe.
Read more at Reuters.com Government Filings News
recommended that girls aged 12 to 13 should be routinely
vaccinated against a virus that causes most cases of cervical
cancer, the Department of Health said on Wednesday.
The move follows similar recommendations in other countries
and is a further boost for Merck & Co Inc. and
Sanofi-Aventis SA , who jointly market Gardasil, the
only such vaccine so far approved in Europe.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment